Skip to content
Tuesday, November 17, 2026
BetTracker

Zimbabwe Rejects ‘One-Sided’ American Healthcare Assistance Deal Due to Information Fears

Medical aid illustration
The proposed American financial assistance would have supported programmes for HIV/Aids treatment and prevention, tuberculosis, and malaria.

Zimbabwe has turned down a major American health deal worth $367m (£272m) spanning five years over Washington's demand for sensitive biological samples.

This rejection came to light after a internal memorandum dated December was leaked, which showed President Emmerson Mnangagwa felt the deal was "skewed".

An official spokesman later explained that the US was seeking genetic material for research and commercial gain while was unwilling to share the benefits from future treatments.

"We are forced to start the challenging and unfortunate process of scaling back our support in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.

The US Embassy said the US had donated more than $1.9bn for health programmes to Zimbabwe over the last twenty years.

A physicians' group in Zimbabwe has urged more negotiations to find a agreement suitable to all parties so the country's vital HIV programme can proceed.

Broader Background

Zimbabwe's decision comes after a similar case in neighbouring Kenya, where a high court suspended a related deal with the US following legal challenges were filed about the security of Kenyans' medical information.

Since resuming the presidency last year, US President Donald Trump has reduced foreign aid and shut down the US Agency for International Development (USAID).

USAID had administered aid for the American government, but Trump argued its expenditure was "inefficient" and his government was pursuing government-to-government deals to enhance openness and responsibility.

According to statements, 16 nations in Africa have to date agreed to these new health pacts, constituting over $18.3bn in new funding.

Specifics of the Rejected Deal

The money for Zimbabwe would have funded "HIV/Aids treatment and prevention, tuberculosis, malaria, maternal and child health, and preparing for epidemics".

"It is our view this collaboration might have yielded extraordinary advantages for the people of Zimbabwe, particularly the 1.2 million men, women and children presently receiving antiretroviral therapy through American-funded programmes," Tremont commented.

However, government spokesperson Nick Mangwana argued the arrangement was "unequal".

"The proposal required Zimbabwe to provide its biological resources and data over an extended period, with no equivalent assurance of access to any medical innovations – like new medicines or tests – that could be developed from that shared data," Mangwana explained.

"Put simply, our country would supply the basic resources for medical research with no assurance that the resulting innovations would be accessible to our population if a new disease outbreak emerge."

National Interest and International Frameworks

He also noted that the American exit from the World Health Organization (WHO) and its push of one-on-one health agreements were undermining structures already set up through the global organization.

Mangwana cited its Pathogen Access and Benefit Sharing scheme created to deal with potential pandemics.

"This system is intended to guarantee that when a nation provides its samples, the benefits – including vaccines and treatments – are distributed fairly, not monopolised exclusively by those with the funds to develop them."

The government's concerns regarding the US deal "should not be misconstrued as opposition to America," Mangwana stressed.

"We encourage further dialogue with our US partners on how subsequent collaboration might be structured in a manner that respects the sovereignty and interests of each country."

Medical Community Reaction

The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it acknowledged the government's concerns, but suggested that negotiations must proceed since a large portion of the nation's HIV programmes relied on international support.

"Where specific concerns exist, including those relating to information security or implementation frameworks, these can often be resolved through detailed discussion and negotiated safeguards," the group commented.

This impasse highlights the continuing debate between receiving much-needed international aid and protecting local interests in an ever more data-driven world.

By

Julie Myers

Marlon Vance is a seasoned sports analyst with over a decade of experience in betting markets, specializing in data-driven predictions and strategy development.

BetTracker

Type to search articles.